Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)Emily K Bergsland, Susan Geyer, Timothy R Asmis, et al.JHEP Reports : Innovation in Hepatology|March 14, 2026
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunctionBridget P Keenan, Zenghua Fan, Bryan Khuong Le, et al.European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDGBrad Kline, Surekha Yadav, Youngho Seo, et al.JCI Insight|November 3, 2018
Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MRSpencer C Behr, Javier E Villanueva-Meyer, Yan Li, et al.Molecular Cancer Research : MCR|June 9, 2017
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate CancerRahul Aggarwal, Spencer C Behr, Pamela L Paris, et al.ACS Chemical Biology|April 8, 2020
A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission TomographyYangjie Huang, Ning Zhao, Yung-Hua Wang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialWolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-11C-YJH08 PETYangjie Huang, Ning Zhao, Yung-Hua Wang, et al.Clinical Colorectal Cancer|March 13, 2026
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal CancerAndrea Bocobo, Julia Whitman, Bridget P Keenan, et al.Pageof 9